Rexulti Tablet
Product Images NDC 59148-035
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Rexulti (NDC 59148-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Otsuka America Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Rexulti 02)
Figure 2 (Rexulti 03)
Figure 3 (Rexulti 04)
Figure 4 (Rexulti 05)
Figure 5 (Rexulti 06)
Figure 6 (Rexulti 07)
Figure 7 (Rexulti 08)
Figure 8 (Rexulti 09)
Principal Display Panel (0.25 mg Tablet Bottle Label)
Principal Display Panel (0.25 mg Tablet Bottle Carton)
Principal Display Panel (0.5 mg Tablet Bottle Label)
Principal Display Panel (0.5 mg Tablet Bottle Carton)
Principal Display Panel (1 mg Tablet Bottle Label)
Principal Display Panel (1 mg Tablet Bottle Carton)
Principal Display Panel (2 mg Tablet Bottle Label)
Principal Display Panel (2 mg Tablet Bottle Carton)
Principal Display Panel (3 mg Tablet Bottle Label)
Principal Display Panel (3 mg Tablet Bottle Carton)
Principal Display Panel (4 mg Tablet Bottle Label)
Principal Display Panel (4 mg Tablet Bottle Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.